MYC, a key regulator of oncogenic metabolism, promotes glycolysis (via LDHA, PFK1), glutamine metabolism (via GLS1), and mitochondrial biogenesis to fuel rapid tumor proliferation.53 The gene discussed is GLS; the disease is neoplasm.